SE0100684D0 - New subject-matter - Google Patents
New subject-matterInfo
- Publication number
- SE0100684D0 SE0100684D0 SE0100684A SE0100684A SE0100684D0 SE 0100684 D0 SE0100684 D0 SE 0100684D0 SE 0100684 A SE0100684 A SE 0100684A SE 0100684 A SE0100684 A SE 0100684A SE 0100684 D0 SE0100684 D0 SE 0100684D0
- Authority
- SE
- Sweden
- Prior art keywords
- subject matter
- new subject
- cervicitis
- situ
- disclosed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0100684A SE0100684D0 (sv) | 2001-02-28 | 2001-02-28 | New subject-matter |
EP02701842A EP1370277B1 (en) | 2001-02-28 | 2002-02-28 | Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis |
AT02701842T ATE504309T1 (de) | 2001-02-28 | 2002-02-28 | Verwendung von oxytocin zur herstellung einer pharmazeutischen zusammensetzung gegen karzinom in situ und zervizitis |
US10/469,255 US7405200B2 (en) | 2001-02-28 | 2002-02-28 | Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis |
JP2002567340A JP2004527496A (ja) | 2001-02-28 | 2002-02-28 | 新規物質 |
PCT/SE2002/000362 WO2002067974A1 (en) | 2001-02-28 | 2002-02-28 | Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis |
DE60239670T DE60239670D1 (de) | 2001-02-28 | 2002-02-28 | Verwendung von oxytocin zur herstellung einer pharmazeutischen zusammensetzung gegen karzinom in situ und zervizitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0100684A SE0100684D0 (sv) | 2001-02-28 | 2001-02-28 | New subject-matter |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0100684D0 true SE0100684D0 (sv) | 2001-02-28 |
Family
ID=20283165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0100684A SE0100684D0 (sv) | 2001-02-28 | 2001-02-28 | New subject-matter |
Country Status (7)
Country | Link |
---|---|
US (1) | US7405200B2 (sv) |
EP (1) | EP1370277B1 (sv) |
JP (1) | JP2004527496A (sv) |
AT (1) | ATE504309T1 (sv) |
DE (1) | DE60239670D1 (sv) |
SE (1) | SE0100684D0 (sv) |
WO (1) | WO2002067974A1 (sv) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0001440D0 (sv) * | 2000-04-18 | 2000-04-18 | Entretech Medical Ab | A drug against climacteric disorders |
AR038085A1 (es) * | 2002-12-27 | 2004-12-29 | Univ Nac Quilmes | Analogos de 1-desamino-8-d-arginina vasopresina |
WO2009033820A2 (en) * | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
KR20100057642A (ko) * | 2007-09-11 | 2010-05-31 | 몬도바이오테크 래보래토리즈 아게 | 치료제로서의 cnp-22 단독 또는 피살라에민과 배합된 이의 용도 |
CA2698768A1 (en) * | 2007-09-11 | 2009-04-02 | Dorian Bevec | Use of a peptide as a therapeutic agent |
WO2009043451A2 (en) * | 2007-09-11 | 2009-04-09 | Mondobiotech Laboratories Ag | Use of chorionic gonadotropin-beta (109-145) as a therapeutic agent |
CA2698754A1 (en) * | 2007-09-11 | 2009-03-19 | Dorian Bevec | Use of a peptide as a therapeutic agent |
SE536091C2 (sv) | 2011-04-14 | 2013-04-30 | Pep Tonic Medical Ab | Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter |
US11414459B2 (en) | 2017-09-28 | 2022-08-16 | Kinoxis Therapeutics Pty Ltd | Metabolite inspired selective oxytocin receptor agonists |
WO2020137880A1 (ja) * | 2018-12-27 | 2020-07-02 | 国立大学法人北海道大学 | オキシトシン誘導体及びその使用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE430885B (sv) * | 1980-03-24 | 1983-12-19 | Ferring Ab | Oxytocin-derivat |
CS255616B1 (cs) * | 1986-07-18 | 1988-03-15 | Petr Simek | Způsob výroby (2-0-metyltyrosin)deamino-1-karbaoxytocinu |
DE4229878A1 (de) * | 1992-09-04 | 1994-03-10 | Knauf Siegfried | Neues Medikament "Oxytocin" zur Bekämpfung der Zuckerkrankheit Typ 1 |
DE4236293A1 (en) | 1992-10-23 | 1993-03-04 | Siegfried Knauf | Use of oxytocin, vasopressin and endorphins - for treatment and prevention of e.g. immunological, neurological and organ diseases and conditions caused by pituitary disorder |
DE4244639A1 (de) * | 1992-10-23 | 1994-07-07 | Knauf Siegfried | Medikament bzw. Medikamentenzusammensetzung |
GB9326354D0 (en) | 1993-12-23 | 1994-02-23 | British Aerospace | Methods and apparatus for the testing,monitoring and improvement of manufacturing process effectiveness |
SE9701162D0 (sv) * | 1997-03-27 | 1997-03-27 | Karolinska Innovations Ab | New use II |
SE9701161D0 (sv) * | 1997-03-27 | 1997-03-27 | Karolinska Innovations Ab | New use I |
SE9803272D0 (sv) * | 1998-09-25 | 1998-09-25 | Kerstin Uvnaes Moberg | A drug for cell regeneration |
SE0001440D0 (sv) | 2000-04-18 | 2000-04-18 | Entretech Medical Ab | A drug against climacteric disorders |
SE0102910D0 (sv) * | 2001-08-31 | 2001-08-31 | Moberg Kerstin Uvnaes | New use |
-
2001
- 2001-02-28 SE SE0100684A patent/SE0100684D0/sv unknown
-
2002
- 2002-02-28 EP EP02701842A patent/EP1370277B1/en not_active Expired - Lifetime
- 2002-02-28 US US10/469,255 patent/US7405200B2/en not_active Expired - Lifetime
- 2002-02-28 DE DE60239670T patent/DE60239670D1/de not_active Expired - Lifetime
- 2002-02-28 JP JP2002567340A patent/JP2004527496A/ja active Pending
- 2002-02-28 AT AT02701842T patent/ATE504309T1/de not_active IP Right Cessation
- 2002-02-28 WO PCT/SE2002/000362 patent/WO2002067974A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
EP1370277B1 (en) | 2011-04-06 |
US7405200B2 (en) | 2008-07-29 |
JP2004527496A (ja) | 2004-09-09 |
US20040176284A1 (en) | 2004-09-09 |
EP1370277A1 (en) | 2003-12-17 |
ATE504309T1 (de) | 2011-04-15 |
DE60239670D1 (de) | 2011-05-19 |
WO2002067974A1 (en) | 2002-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY120235A (en) | Aryloxyarylsulfonylamino hydroxamic acid derivatives | |
MY155218A (en) | Small molecules useful in the treatment of inflammatory disease | |
PT1413582E (pt) | Pirrolobenzodiazepinas dimericas | |
AU7031500A (en) | Therapeutic quinazoline compounds | |
GB0223038D0 (en) | Therapeutic compounds | |
GB0225474D0 (en) | Therapeutic agents | |
GEP20022678B (en) | Bicyclic Heteroaromatic Compounds As Protein Tyrosine Kinase Inhibitors, their Pharmaceutical compositions and methods for Treatment | |
BR0212042A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto | |
DE60234577D1 (de) | Pharmazeutische mischung zur behandlung von krebs, die dioxolan nukleosidanalogen enthält | |
MXPA05006359A (es) | Tratamiento de la enfermedad a traves de inhibidores peptidos antimicrobianos. | |
WO2002053101A3 (en) | Method for treating fibrotic diseases or other indications | |
NZ516349A (en) | Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease | |
TR200101120T2 (tr) | Serin proteaz inhibitörü | |
ATE495187T1 (de) | Dalda-analoge und ihre verwendung | |
BR0015992A (pt) | Compostos, utilização dos mesmos, e, associações terapêuticas | |
AU2001247968A1 (en) | Use of asiatic acid or asiaticoside for treatment of cancer | |
SE9802208D0 (sv) | Novel compounds | |
SE0100684D0 (sv) | New subject-matter | |
ATE238981T1 (de) | Antitumorwirkstoffe | |
GB0130677D0 (en) | Medicaments and novel compounds | |
EE04055B1 (et) | Ühendid ja kompositsioonid seriinproteaasse, eriti trüptaasse aktiivsusega seotud haiguste raviks, ja nende kasutamine | |
IL124015A0 (en) | Pharmaceutical compositions comprising a protein | |
DE60129829D1 (de) | Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie | |
GB9907571D0 (en) | Compounds | |
TR200101245T2 (tr) | N-arilsulfonil-aminoasit-omega-amidler |